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rInsulin-like Growth Factor I – A Novel Biomarker of Abdominal
Aortic Aneurysms
Lindholt J.S., Martin-Ventura J.L., Urbonavicius S., Ramos-Mozo P., Fly-
vbjerg A., Egido J., Henneberg E.W., Frystyk J. Eur J Vasc Endovasc Surg
2011;42:560-2.
Objective: The study aimed to test the potential role of insulin-like
growth factor I (IGF-I) and IGF-II as biomarkers for abdominal aortic
aneurysm (AAA).
Methods and results: IGF-I and II levels were analysed in 115 patients
with screening diagnosed AAA kept under annual surveillance for 10 years.
Serum IGF-I correlated positively with AAA size and growth rate (r  0.23,
P  0.016 and r  0.27, P  0.004), persisting after adjustment for poten-
tial confounders. Serum IGF-I level predicted cases needing later surgery
(AOC: 0.63; 95% confidence interval: 0.52–0.73).
Conclusions: In this prospective, long-term study, baseline serum
IGF-I correlated positively with AAA size and growth rate and predicted
future need for preventive surgery.
Elective Endovascular vs. Open Repair for Abdominal Aortic Aneu-
rysm in Patients Aged 80 Years and Older: Systematic Review and
Meta-Analysis
Biancari F., Catania A., D’Andrea V. Eur J Vasc Endovasc Surg 2011;42:
571-6.
Objectives: Endovascular treatment (EVAR) of abdominal aortic an-
eurysm (AAA) is thought to be of benefit, particularly in patients aged 80
years. This issue was investigated in the present meta-analysis.
Design: The study design involved a systematic review of the literature
and meta-analysis.
Methods: Systematic review of the literature and meta-analysis of data
on elective EVAR vs. open repair of AAA in patients aged 80 years were
performed.
Results: Six observational studies reporting on 13 419 patients were
included in the present analysis. Pooled analysis showed higher immediate
postoperative mortality after open repair compared with EVAR (risk ratio
3.87, 95% confidence interval (CI) 3.19–4.68; risk difference, 6.2%, 95%CI
5.4–7.0%). The pooled immediate mortality rate after open repair was 8.6%,
whereas it was 2.3% after EVAR. Open repair was associated with a signifi-
cantly higher risk of postoperative cardiac, pulmonary and renal complica-
tions. Pooled analysis of three studies showed similar overall survival at 3
years after EVAR and open repair (risk ratio 1.10, 95%CI 0.77–1.57).
Conclusions: The results of this meta-analysis suggest that elective
EVAR in patients aged 80 years is associated with significantly lower
immediate postoperative mortality and morbidity than open repair and
should be considered the treatment of choice in these fragile patients. These
results indicate also that, when EVAR is not feasible, open repair can be
performedwith acceptable immediate and late survival in patients at high risk
of aneurysm rupture.
The Role of Cell Salvage Autotransfusion in Abdominal Aortic Aneu-
rysm Surgery
Shantikumar S., Patel S., Handa A. Eur J Vasc Endovasc Surg 2011;42:577-
84.
Objective: Abdominal aortic aneurysm (AAA) repairs, both elective
and rupture, are associated with significant blood loss often requiring
transfusion. Cell-salvage autotransfusion has been developed to reduce the
need for allogeneic blood. We review the literature to delineate the role of
cell salvage in reducing allogeneic blood use in open AAA repairs.
Methods: A systematic search of the English-language literature was
performed using the PubMed, Embase and Cochrane databases up to
August 2010.
Results: Twenty-three studies were identified. Whilst some data are
conflicting, cell salvage appears to reduce overall use and exposure to
allogeneic blood, and reduces length of intensive care unit and hospital stay
after elective AAA repairs. There may be additional benefit by combining cell
salvage with other blood-conservation techniques. Use of cell salvage in
ruptured AAA repairs consistently reduced blood-product requirements.Conclusions:Cell salvage appears to reduce blood-product use in both
elective and rupture AAA repairs. Owing to the heterogeneity in methodol- i
1538gy of published data, further study may be required before cell salvage
ecomes standard practice in open AAA repairs.
eterogeneity in Surveillance after Endovascular Aneurysm Repair in
he UK
arthikesalingam A., Page A.A., Pettengell C., Hinchliffe R.J., Loftus I.M.,
hompson M.M., Holt P.J.E. Eur J Vasc Endovasc Surg 2011;42:585-90.
Objectives: Surveillance after Endovascular Aneurysm Repair (EVAR)
s considered mandatory, but the optimal regimen remains controversial.
he aim of the present study was to report the nature of routine post-EVAR
urveillance protocols in the UK, in order to identify the degree of variation
n national practice and from the manufacturer’s instructions for use (IFU).
Methods: A telephone survey was administered to 41 centres with 10
ears’ experience in EVAR to identify their standard surveillance protocol
fter EVAR.Data were collected regarding the number of surveillance CT or
ltrasound performed up to 5 years postoperatively.
Results: 12/41 centres used CT as the primary mode of surveillance,
4/41 centres used USS as the primary mode of surveillance, and 15/41
entres used a combination of CT andUSS. The mean  s.d. number of CT
cans performed cumulatively up to 1 year and 5 years post surgery were
.1  0.6 and 3.5  2.9 respectively. The mean  s.d. ultrasound scans
erformed at 1 year and 5 years post surgery were 0.5  0.9and 4.7  3.6
espectively.
Conclusions: Significant heterogeneity exists in surveillance after
VAR in the UK. Efforts should be made to establish consensus towards a
ational surveillance protocol.
greement between Computed Tomography and Ultrasound on Ab-
ominal Aortic Aneurysms and Implications on Clinical Decisions
oo F.J., Hammond C.J., Goldstone A.R., Abuhamdiah M., Rashid S.T.,
est R.M., Nicholson A.A., Scott D.J.A. Eur J Vasc Endovasc Surg 2011;
2:608-14.
Objectives: The United Kingdom abdominal aortic aneurysm (AAA)
creening programme refers aneurysms with ultrasound (US) diameters of
5.5 cm to vascular services for consideration of computed tomography
CT) and intervention. We investigated the discrepancy between US and
T, implications on clinical decisions and question at which stage CT be
sed.
Design/methods: AAA USs over 5 years were retrospectively anal-
sed. Patients included had aneurysms measuring 5 cm on US with
ubsequent CT within 2 months (n  123). Based on maximum US diam-
ters, 44 patients had aneurysms between 5 and 5.4 cm (group I) and 79
atients5.5 cm (group II). Results were cross-referenced. Correlation and
imits of agreement were calculated. Two radiologists re-measured 44 pairs
f CT/US scans and the inter-observer bias in determining discrepancies
etween imaging modalities calculated.
Results: Mean difference between imaging modalities was 0.21 cm
0.39 cm, p  0.001). Limits of agreement were 0.55 to 0.96 cm,
xceeding clinical acceptability. Mean difference was higher and significant
n group I (0.39 cm, p  0.001) compared to group II (0.10 cm, p  0.05).
eventy-percent of group I patients had CT scans revealing diameters of
5.5 cm. Inter-observer bias was not significant.
Conclusion: Significant differences between imaging modalities, more
n US diameters of below 5.5 cm, exist. We recommend AAAs measuring
5 cm on US should undergo earlier referral to a vascular service and CT.
Systematic Review of Mid-term Outcomes of Thoracic Endovascular
epair (TEVAR) of Chronic Type B Aortic Dissection
hrumurthy S.G., Karthikesalingam A., Patterson B.O., Holt P.J.E.,
inchliffe R.J., Loftus I.M., Thompson M.M. Eur J Vasc Endovasc Surg
011;42:632-47.
Objective and design: The role of Thoracic Endovascular Repair
TEVAR) in chronic type B aortic dissection remains controversial and its
id-term success as an alternative to open repair or best medical therapy
emains unknown. The aim of the present study was to provide a systematic
eview ofmid-term outcomes of TEVAR for chronic type B aortic dissection.Materials and methods:Medline, trial registries, conference proceed-
ngs and article reference lists from 1950 to January 2011 were searched to
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B dissection. Data were extracted for review.
Results: 17 studies of 567 patients were reviewed. The technical
success rate was 89.9% (range 77.6–100). Mid-term mortality was 9.2%
(46/499) and survival ranged from 59.1 to 100% in studies with a median
follow-up of 24 months. 8.1% of patients (25/309) developed endoleak,
predominantly type I. Re-intervention rates ranged from 0 to 60% in studies
with a median follow-up of 31 months. 7.8% of patients (26/332) devel-
oped aneurysms of the distal aorta or continued false lumen perfusion with
o
rneurysmal dilatation. Rare complications included delayed retrograde type
dissection (0.67%), aorto-oesophageal fistula (0.22%) and neurological
omplications (paraplegia 2/447, 0.45%; stroke 7/475, 1.5%).
Conclusion: The absolute benefit of TEVAR over alternative treat-
ents for chronic B-AD remains uncertain. The lack of natural history data
or medically treated cases, significant heterogeneity in case selection and
bsence of consensus reporting standards for intervention are significant
bstructions to interpreting the mid-term data. High-quality data from
egistries and clinical trials are required to address these challenges.
